BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giacomini KM, Yee SW, Koleske ML, Zou L, Matsson P, Chen EC, Kroetz DL, Miller MA, Gozalpour E, Chu X. New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook from the International Transporter Consortium. Clin Pharmacol Ther 2022. [PMID: 35488474 DOI: 10.1002/cpt.2627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Özvegy-Laczka C, Ungvári O, Bakos É. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox. Biochem Pharmacol 2023;209:115448. [PMID: 36758706 DOI: 10.1016/j.bcp.2023.115448] [Reference Citation Analysis]
2 Gyimesi G, Hediger MA. Transporter-Mediated Drug Delivery. Molecules 2023;28. [PMID: 36770817 DOI: 10.3390/molecules28031151] [Reference Citation Analysis]
3 Nies AT, Schaeffeler E, Schwab M. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. Pharmacology & Therapeutics 2022;238:108268. [DOI: 10.1016/j.pharmthera.2022.108268] [Reference Citation Analysis]
4 Giacomini KM, Huang SM. More Than Pharmacokinetics: Transporters in Clinical Pharmacology. Clin Pharmacol Ther 2022;112:423-6. [PMID: 35989454 DOI: 10.1002/cpt.2710] [Reference Citation Analysis]
5 Chu X, Prasad B, Neuhoff S, Yoshida K, Leeder JS, Mukherjee D, Taskar K, Varma MVS, Zhang X, Yang X, Galetin A. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Clin Pharmacol Ther 2022. [PMID: 35561140 DOI: 10.1002/cpt.2643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]